Evidence map›Paper›PMID 40917014›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Cobalt and Yttrium Doping to Activate Dual-Site Mechanism of Amorphous NiFeOOH for Large-Current Water Electrooxidation.

Xiaojing Lv, Mingzhe Li, Hongye Qin, Lifang Jiao, Yuzhen Lv, Hongyun Luo, Wei Zhou, Lin Guo

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Dynamic Cobalt Leaching-Redeposition Equilibrium in CoAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaojing LvHangzhou International Innovation Institute, Beihang University, Hangzhou, 311115, China.
Mingzhe LiSchool of Energy, Power and Mechanical Engineering, North China Electric Power University, Beijing, 102206, China.
Hongye QinKey Laboratory of Advanced Energy Materials Chemistry (Ministry of Education), Collaborative Innovation Center of Chemical Science and Engineering, College of Chemistry, Nankai University, Tianjin, 300071, China.
Lifang JiaoKey Laboratory of Advanced Energy Materials Chemistry (Ministry of Education), Collaborative Innovation Center of Chemical Science and Engineering, College of Chemistry, Nankai University, Tianjin, 300071, China.ORCID https://orcid.org/0000-0002-4676-997X
Yuzhen LvSchool of Energy, Power and Mechanical Engineering, North China Electric Power University, Beijing, 102206, China.ORCID https://orcid.org/0000-0002-0718-264X
Hongyun LuoSchool of Materials Science and Engineering, Beihang University, Beijing, 100191, China.
Wei ZhouHangzhou International Innovation Institute, Beihang University, Hangzhou, 311115, China.ORCID https://orcid.org/0000-0003-0659-7824
Lin GuoHangzhou International Innovation Institute, Beihang University, Hangzhou, 311115, China.

Funding

Beijing Nova Program 20240484537National Natural Science Foundation of China 22479003National Natural Science Foundation of China 51972011National Natural Science Foundation of China 52172176Taihu Lake Innovation Fund for Future Technology
6 · The paper itself

Abstract

The difference in hydroxyl adsorption between Ni and Fe sites in NiFeOOH limits the efficient dual-site synergistic mechanism (DSSM) during oxygen evolution reaction (OER). Here, a novel needle-array electrodeposition is reported for the scalable and efficient fabrication of Co and Y co-doped NiFeOOH catalyst. It achieves an ultralow overpotential of 270 mV at 1 A cm

Indexed as

dopingdual‐site mechanismkineticsnickel‐ironoxygen evolution reaction

Identifiers

PMID40917014
PMCPMC12677668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.